Anita Chamba

Summary

Affiliation: University of Birmingham
Country: UK

Publications

  1. ncbi Characterisation of the endogenous human peripheral serotonin transporter SLC6A4 reveals surface expression without N-glycosylation
    Anita Chamba
    Division of Immunity and Infection, The Medical School, University of Birmingham, Birmingham, 815 2TT, United Kingdom
    J Neuroimmunol 204:75-84. 2008
  2. ncbi The serotonin transporter (SLC6A4) is present in B-cell clones of diverse malignant origin: probing a potential anti-tumor target for psychotropics
    Elizabeth J Meredith
    Division of Immunity and Infection, The Medical School, Birmingham, UK
    FASEB J 19:1187-9. 2005
  3. ncbi Enhancing the anti-lymphoma potential of 3,4-methylenedioxymethamphetamine ('ecstasy') through iterative chemical redesign: mechanisms and pathways to cell death
    Agata M Wasik
    School of Immunity and Infection, The Medical School, Birmingham, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK
    Invest New Drugs 30:1471-83. 2012
  4. ncbi Selective serotonin reuptake inhibitors directly signal for apoptosis in biopsy-like Burkitt lymphoma cells
    Adamantios Serafeim
    Medical Research Council Centre for Immune Regulation, School of Biosciences, University of Birmingham, Birmingham, United Kingdom
    Blood 101:3212-9. 2003

Collaborators

  • Dagmar Scheel-Toellner
  • Martin J S Dyer
  • Michelle J Holder
  • Nicholas M Barnes
  • John Gordon
  • Agata M Wasik
  • Anita Challa
  • Elizabeth J Meredith
  • Mark T Drayson
  • Christopher M Bunce
  • Adamantios Serafeim
  • Katie D Lewis
  • Michael N Gandy
  • Stephen P Young
  • Matthew McIldowie
  • Matthew J Piggott
  • Geoffrey Pilkington
  • Adrian Drake-Lee
  • Randy D Blakely
  • Quang T Luong
  • Christopher D Gregory
  • Gillian Grafton

Detail Information

Publications4

  1. ncbi Characterisation of the endogenous human peripheral serotonin transporter SLC6A4 reveals surface expression without N-glycosylation
    Anita Chamba
    Division of Immunity and Infection, The Medical School, University of Birmingham, Birmingham, 815 2TT, United Kingdom
    J Neuroimmunol 204:75-84. 2008
    ..Biotinylation of lymphoid cells revealed that the endogenous non-glycosylated 60 kDa but not 70 kDa protein was available at the surface to access exogenous ligands...
  2. ncbi The serotonin transporter (SLC6A4) is present in B-cell clones of diverse malignant origin: probing a potential anti-tumor target for psychotropics
    Elizabeth J Meredith
    Division of Immunity and Infection, The Medical School, Birmingham, UK
    FASEB J 19:1187-9. 2005
    ....
  3. ncbi Enhancing the anti-lymphoma potential of 3,4-methylenedioxymethamphetamine ('ecstasy') through iterative chemical redesign: mechanisms and pathways to cell death
    Agata M Wasik
    School of Immunity and Infection, The Medical School, Birmingham, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK
    Invest New Drugs 30:1471-83. 2012
    ..In conclusion, MDMA analogues have been discovered with enhanced cytotoxic efficacy against lymphoma subtypes amongst which high-level Bcl-2--often a barrier to drug performance for this indication--fails to protect...
  4. ncbi Selective serotonin reuptake inhibitors directly signal for apoptosis in biopsy-like Burkitt lymphoma cells
    Adamantios Serafeim
    Medical Research Council Centre for Immune Regulation, School of Biosciences, University of Birmingham, Birmingham, United Kingdom
    Blood 101:3212-9. 2003
    ....